Clinical and immunological studies in patients with an increased serum IgD Level by Hiemstra, I. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
This full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/14841
 
 
 
Please be advised that this information was generated on 2014-11-11 and may be subject to
change.
Journal o f  Clinical Immunology, Vol. 9, No. 5, 1989
Clinical and Immunological Studies in Patients with an 
Increased Serum IgD Level
ID S K E  H IE M S T R A ,1,2 JA A K  M . V O S S E N ,1 JOS W . M. V A N  D E R  M E E R ,1 C O R R IE  M . R. 
W E E M A E S ,1 T H E O  A. O U T ,1 and B E N  J. M . Z E G E R S 1
Accepted: June 12, 1989
Increased levels of serum IgD can be found in single 
patients with a variety of clinical syndromes and in the 
disease entity designated hyper-IgD syndrome which is 
associated with periodic fever and lymphadenopathy. We 
investigated 17 patients, both children and adults, with 
high serum IgD levels ranging from 220 to 5300 IU/ml. 
Eight patients had periodic fever and lymphadenopathy, 
four showed a humoral immunodeficiency, and the re­
mainder had a variety of clinical abnormalities. Serum 
IgA levels were consistently high in all patients except in 
those with an immunodeficiency. Serum IgD complexes 
were detectable in each serum, which indicates that the 
occurrence is not pathognomic for the syndrome of 
periodic fever. Antibody formation against the primary 
antigen Helix pomatia hemocyanine and the secondary 
antigen tetanus toxoid showed no abnormalities in the 
patients without an immunodeficiency. Bone marrow 
origin of serum IgD was strongly suggested by enumera­
tion of IgD-containing plasma cells. We conclude that no 
apparent relationship exists between the several clinical 
syndromes and increased serum IgD.
KEY WORDS: Serum IgD; periodic fever; imm unodeficiency; 
im m une status.
INTRODUCTION
T h e  function  of the  hum an im m unoglobulin  iso type 
IgD , as identified in 1964 by R ow e and F ahey  (1), is 
still no t com pletely solved. T h e  IgD m olecule oc­
cu rs  as m em brane-bound p ro tein  on lym phocytes o f
’D utch W orking Group for Immunodeficiencies, Secretariat 
N ieuw e G racht 137, 3512 LK Utrecht, The N etherlands. (Par­
ticipants in this study: Drs. P. J. A. van M unster and J. A. 
Bakkeren, Nijmegen; Dr. M. Daha, Leiden; Dr. R. S. W eening, 
A m sterdam ; Dr. E. R. de Graeff-Meeder, U trecht, and D rs. C. 
Kallenberg and M. van der Giessen, Groningen.)
2T o  whom correspondence should be addressed at University 
H ospital for Children and Youth, “ H et W ilhelmina K inderziek­
enhu is ,”  P.O . Box 18009, 3501 CA U trecht, T he N etherlands.
B-cell lineage and also in serum  and o ther body 
fluids. M em brane-bound IgD probably  plays a  role 
in antigen-triggered B -lym phocyte differentiation 
(2, 3). A lthough an tibody  activity  can  be detected  in 
soluble serum  IgD , its role in the  defense against 
infections is less c lear since effector functions such 
as binding to  phagocytes are  lacking (4, 5).
IgD com prises abou t 1% o f the to ta l serum  im m u­
noglobulin pool in m an. T he concen tra tion  in serum 
as m easured  in healthy  infants and adults is age 
dependent and show s a  considerab le  biological vari­
ation w ithin people o f the  sam e age (1, 6, 7). Serum 
IgD levels o f a population  are  not norm ally distrib­
uted (7). D unette  et cil. (8) show ed in a study o f  300 
individuals aged 6 to  18 years tha t about 14% o f the 
individuals had an extrem ely  low serum  IgD. The 
la tter phenom enon appeared  to be genetically  de­
term ined, in  tha t an  au tosom al recessive pattern  of 
inheritance and an  H L A  associa tion  w ere described 
(8, 9). In co n trast, a substan tia l num ber o f healthy 
individuals show ed an increased  serum  IgD level (1, 
7, 8; unpublished observations o f O ut, V ossen, and 
Zegers), bu t a  d iscernible inheritance pattern  or 
H L A  association  w as no t dem onstrab le  (8).
The role o f serum  IgD  in disease is not clear. 
Increased  serum  IgD levels are found in patients 
with various types o f  im m unodeficiency d iseases, in 
patients w ith severe recu rren t infections o f the 
resp iratory  trac t, and in single patien ts w ith a 
variety  o f clinical syndrom es or abnorm alities (10). 
R ecently  a  clinical d isease  en tity  has been de­
scribed, designated  the hyper-IgD  syndrom e, which 
is characterized  by  period ic  fever and lym phade­
nopathy asso c ia ted  w ith strongly increased  levels of 
serum  IgD o f up to  6000 IU /m l serum  (11).
S ince w e w ere in te rested  in  the ro le o f  serum  IgD 
in d isease a m ulticen ter study  w as designed aimed
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to analyze th e  clinical and im m unological findings in 
a series o f pa tien ts w ith a varie ty  o f d iagnoses and 
with high serum  IgD levels w hich w ere under the 
care of the  m em bers o f  th e  D utch W orking G roup 
for Im m unodeficiencies. T he m ain  crite rion  for en ­
try in the study  w as a level of serum  IgD equal o r 
higher than 150 IU /m l as de term ined  on tw o  occa­
sions with an  in terval o f a t least 1 m onth.
PATIENTS AND METHODS
Patients w ere  en tered  in to  this m u lticen ter study  
after inform ed co n sen t w as ob ta ined . T h e  en try  
criterion w as a serum  IgD  level higher than  150 
IU/ml on tw o occasions a t le a s t 1 m onth  apart. 
Included w ere  6 adults and  11 ch ildren ; age varied 
between 3 and  60 years.
The data  w ere co llected  according to  a p ro tocol 
written by  the  D utch  W orking G roup fo r Im m uno­
deficiencies (see Table I).
With re sp ec t to  the h isto ry  o f  the  patien t and 
his/her fam ily, special a tten tio n  was paid  to infec­
tious d iseases, recu rren t fever, v accination  sequela, 
allergic sym ptom s, m alignancy, au toim m une dis­
eases, tonsillectom y, adeno tom y, and  appendec­
tomy.
White b lood-cell coun t, total lym phocy te  counts, 
routine urine analysis, serum  au toan tibod ies such 
as antibodies against e ry th ro cy tes , an tinuclear an ­
tibodies, an ti-doub le-stranded  D N A , rheum ato id  
factors, and serum  im m unoglobulin (Ig) levels w ere 
determ ined b y  standard  m ethods.
Table I. Protocol Design
Time (days)
0 14 21 35 63 120 240 360
Physical examination,
routine laboratory" x
Tetanus toxoid booster X
Tetanus toxoid
antibodies X X
HPH immunization X
HPH antibodies X X  X
Serum IgD levels X X X X
Bone marrow X
Cellular immunity* X X
"White blood-cell count, total lym phocyte count, urine analysis, 
serum autoantibodies, serum  immunoglobulin levels, and saliva 
collection.
‘Circulating B- and T-ceil num bers and in vitro proliferative 
responses o f lym phocytes to m itogens, antigens, and allogeneic 
cells.
Saliva w as collected during 15 min according to 
Lourie (12). The first specim en was discarded; in 
th e  second specim en IgM , IgG, IgA, and IgD levels 
w ere  m easured (13, 14).
IgD com plexes w ere determ ined by Dr. M. R. 
D aha (Leiden) in serum  that had been im m ediately 
frozen  at -7 0 °C . A fter precipitation w ith  polyeth- 
yleneglycol 6000 (final concentration , 3.5%), high 
m olecular weight IgD (presum ably IgD com plexes) 
w as m easured w ith a rad io im m unoassay  using 
m onoclonal anti-IgD  an tibody ; re su lts  a re  ex­
p ressed  as the percentage o f  a positive control 
serum  containing 739 ng IgD com plexes/m l.
Patients w ere imm unized w ith the secondary  an­
tigen tetanus toxoid and specific antibodies in the 
IgG  and IgD class before and after im m unization 
w ere  m easured by an enzym e-linked im m unosor­
ben t assay (ELISA ) (15). Im m unization w ith 1 mg 
o f  the prim ary antigen H elix  pom atia  haem ocyanin 
(HPH) was perform ed subcutaneously  in the deltoid 
region, and class-specific antibody levels (IgM, 
IgG , IgA, and  IgD) w ere m easured by an  E L ISA  in 
serum  obtained before and 14 and 42 days after 
im m unization; H PH  antibodies w ere expressed  as a 
percentage o f  a positive reference sam ple as de­
scribed (16).
In  vitro pro liferative responses o f  peripheral 
blood m ononuclear cells to the m itogens phytohe­
magglutinin (PHA), poke w eed m itogen (PW M ), and 
concanavalin A (Con A), to the antigens tetanus 
toxoid, Candida albicans, and H PH , and to alloge­
neic cells w ere determ ined w ith standard  m ethods.
Circulating B cells w ere enum erated as surface 
Ig-positive cells and p. and 8 expression was deter­
m ined as described (17). T-cell num bers w ere de­
term ined using the m onoclonal antibody OKT3 
(CD3) (Ortho Pharm aceuticals, R aritan , NJ).
Bone m arrow  specim ens w ere an a ly zed  for 
plasm a cells by cytoplasm ic im m unofluorescence 
fo r  IgM, IgG , IgA, and IgD (18). A lso, com bined 
staining for the presence of surface IgM  (slgM ) and 
slgD  on small cytoplasm ic IgM (clgM )-positive 
cells, on large clgM -positive, and on  large clgD- 
positive cells was perform ed.
RESULTS
Clinical findings and levels o f serum  IgM, IgG, 
IgA , IgD, and IgE are presen ted  in T able II. All 17 
patients had an elevated  serum  IgD (range, 175— 
5300 IU/ml). Patients 1 to 8 suffered from  a syn­
drom e characterized by periodic fever from  the  age
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Table II. Survey of the Clinical D ata of the Patients and the Levels o f  Serum IgM, IgG, IgA, IgD, and IgE"
Patient
No. Age Sex Diagnosis
IgM
(g/L)
IgG
(g/L)
IgA
(g/L)
IgD
(IU/ml)
IgE
(IU/ml)
1 10 9 Periodic fever 1.56 14.1 3.3 312 16
2 10 Periodic fever 1.02 16.1 3.3 1450 <100
3 10 d Periodic fever 0.93 16.3 6.3 1180 5
4 7 9 Periodic fever 0.45 9.3 2.1 3250 23
5 20 9 Periodic fever 0.77 5.6 3.1 5300 <100
6 35 9 Periodic fever 1.2 9.6 2.6 1068 12
7 6 d Periodic fever 0.95 7.2 3.2 2813 42
8 16 â Periodic fever 0.99 11.3 3.3 175 40
9 4 S H einer syndrome 0.98 15.1 1.3 198 1500
10 17 Ô H ay fever 1.88 15.0 2.7 262 450
11 3 $ Bronchiectasis 1.19 28.1 4.2 1800 414
12 10 a Postinfectious arthritis 1.8 11.5 2.5 220 154
13 60 s Rheum atoid arthritis 1.0 25.7 7.8 636 2300
14 23 6 XLA 0 9.6 0 318 9
15 27 â XLA Trace 5.8-7.0 0 190 <1
16 17 $ CVID 0.88 3 .7 0.04 191 2
17 40 â IgM  deficiency <0.3 9.9 3.2 316 <1
18 14 S Healthy control 1.17 8.2 1.8 64 1200
aThe italicized data o f the serum immunoglobulin levels indicate a  deviation of the normal level. For IgM, IgG, IgA, and IgD the levels 
from  Ref. 13 are used; for IgE, Ref. 19.
o f  4 m onths onw ard. The fev e r recu rs every 1 to 2 
m on ths; an  episode lasts 2 to  3 days and is som e­
tim es accom panied by an erysipelas-like rash , cer­
v ical lym phadenopathy, abdom inal pain , and arthri­
tis . N o v iral causes have b een  identified (except 
p a tien t 2, who suffers from  a  pers is ten t E p ste in - 
B arr v irus infection). Clinically the  syndrom e o f 
period ic  fever resem bles, to  som e ex ten t, familial 
M ed iterranean  fever (FM F) b u t th e  response to  
colchicine is equivocal. In p a tien t 2 a hypoaller- 
genic d iet seem s to  be successful (personal com m u­
nica tion  o f Dr. R . S. W eening). P atien ts 3 and 4 are 
siblings from  healthy nonconsanguinous paren ts. 
P atien ts  5, 6, and  8 have been  described  earlier (11). 
The illness o f patien t 8 (see R ef. 11) resem bles F M F  
very  m uch; his response to  colch icine is favorable, 
and  his m other and m aternal uncle  suffered from  the 
sam e syndrom e com plicated by renal am yloidosis. 
In  p a tien t 9 the diagnosis o f H e in e r syndrom e, i.e ., 
p u lm onary  hem osiderosis and co w ’s milk allergy, 
w as m ade. Patien t 10 has allergic pollinosis. H e 
becam e donor o f  a bone m arrow  transp lan t to his 
H L A -identical b rother, w ho suffered from  acute 
leukem ia. A lthough serum  im m unoglobulins in the  
rec ip ien t have reached  norm al values after tran s­
p lan ta tion , no increase in serum  IgD is seen. Patien t 
11 show ed bronchiectasis o f  unknow n etiology and 
p atien t 12 presen ted  w ith tran s ien t arth ritis a fter 
infection. Patien t 13 had rheum ato id  arthritis asso ­
c iated  w ith polyclonal gam m apathy.
P atien ts 14-17 have various types o f humoral 
im m unodeficiency syndrom es. T he serum  im m uno­
globulin values o f  pa tien t 16 date from  before y- 
globulin substitu tion ; the  o thers w ere investigated 
while on substitu tion  therapy . Serum  IgG w as in­
creased  in  several p a tien ts; serum  IgG subclass 
levels w ere  not deficient (data  not show n). IgM was 
norm al ex cep t fo r the  patien ts  w ith the  im m unode­
ficiency syndrom es. R em arkably  there  was an in­
crease in serum  IgA levels in a lm ost every  patient. 
Serum  IgE  w as increased  in four pa tien ts , N os. 9, 
10, 11, an d  13; all bu t one have pulm onary  prob­
lems. T h ere  w as no correlation  betw een  IgE  and 
IgD serum  levels.
Table III  show s the levels o f im m unoglobulins in 
saliva. T he resu lts show  th a t IgD  w as increased  in 
only 4 o f  10 patien ts, and secre to ry  IgA  in 2 of 10.
T he resu lts  o f  analysis o f  serum  IgD com plexes 
show ed  th e  p re se n c e  o f  p o ly e th y le n e  glycol- 
p recip itab le  IgD in each  sam ple investigated. A 
rem arkab le, linear co rrela tion  w as detected  be­
tw een th e  serum  IgD level and serum  IgD com ­
plexes (/- =  0.87; Fig. 1). W hen the polyethylene- 
glycol p rec ip ita tes fro m  th ree  sera  w ere analyzed 
by gel filtra tion  on  Sephacry l S300, the samples 
contained  an ti-IgD -reactive m aterial w ith m olecular 
w eights h igher than  300 kD , suggesting the  occur­
rence  o f  e ith er aggregated IgD o r IgD in immune 
com plex form .
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Table III. Saliva IgM, IgG, IgA, and IgD Levels"
Patient Age Sex
IgM
(mg/L)
IgG
(mg/L)
IgA
(mg/L)
IgD
(lU/mt)
1 10 9 4.1 3.1 97.9 0.13
7 6 9 0.9 <0.4 21.2 0.06
8 16 d <0.4 <0.4 5^5 <0.02
9 4 d 0.75 0.5 30.6 <0.02
10 17 d < 0.4 <0.4 78.5 <0.02
13 60 d < 0 .4 <0.4 2.9 <0.02
14 23 d n.d.* n.d. 5.4 0.98
15 27 d < 0 .4 6.0 0.7 0.30
16 17 d 7.5 41.0 21.7 1.48
17 40 d < 0 .4 <0 .4 101.3 0.04
18 14 d 0.5 0.4 31.0 <0.02
Control values1' 1.01c <0.3 '' 44.21' <0.02
(0.76) (32.8)
"The italicized data indicate a  deviation o f the norm al level. 
*Not done.
‘Reference 14; mean (SD); A' =  9; age, 10-24 years.
A fter im m unization w ith  the prim ary  antigen H e ­
lix pom atia  hem ocyanine (H PH ) the IgM -, IgG-, 
and IgA -class antibody  response in severa l patien ts 
is below th a t seen in norm al adults (Fig. 2). C om ­
pared to age-m atched controls (20) th e  H P H  anti­
body response  is com pletely  norm al. P atien ts  14- 
17, having a hum oral im m unodeficiency, all show ed 
no response  follow ing H PH  im m unization  and 
those resu lts are  no t included in Fig. 2. F ive  o f 15 
patients show  detec tab le  an ti-H PH  resp o n ses  in the 
IgD class. B ooster im m unization w ith  th e  second­
ary antigen te tanus toxoid show ed a significant rise 
in an tite tanus antibodies in all p a tien ts  excep t fo r
10000.
1000.
^ 100.
2
E
S0)w
c
Fig. 1. Correlation between the serum level o f IgD and the 
quantity of IgD complexes.
the im m unodeficient patients. The range o f the 
ratios betw een  the post- and the preim m unization 
titers of the patients did no t differ significantly from 
that in controls. In patients 1, 8 and 13 and in the 
control, 18, an antibody response to te tanus toxoid 
in the IgD class was dem onstrable. Only one of 
these patien ts showed an anti-H PH  response  o f the 
IgD class. In  patients w ith periodic fev e r the immu­
nization w ith tetanus toxoid induced a classical 
attack (11). In  contrast hem ocyanine im m unization
10.  100. 
IgD  complexes in serum: %  of control
Fig. 2. A ntibody form ation against H elix pom atia  hem ocyanine in patients with increased serum IgD. Areas betw een dashed lines 
represent m easurem ents ±  1 SD obtained in 14 normal adult controls (16). Stippled areas represent the results obtained in 
age-matched normal children (20).
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Table IV. Analysis o f Cells o f the B Lineage in Bone Marrow*1
(A) Ig-containing cells/105 lymphocytes and plasma cells
Patient No. Age Diagnosis clgM clgG clgA clgD
1 10 pf 469 1856 1048 928
2 10 Pf 108 624 401 924
3 10 Pf 125 1117 2921 5128
4 7 Pf 51 491 448 1383
5 20 Pf 30 79 876 4145
6 35 Pf 104 721 567 1668
7 6 Pf 134 428 323 1988
8 16 Pf 262 999 794 287
9 4 H einer syndrome 99 899 392 309
10 17 H ay fever 491 626 856 964
13 60 r.a. 53 •793 517 405
14 23 X LA 0 33 0 85
15 27 XLA 54 229 0 373
16 17 CVID 645 16 0 629
17 45 IgM deficiency 276 1734 2071 883
18 14 Control 156 621 374 56
Control values*
2 -6  healthy 34-203 35-268 49-348 0-29
6-15 healthy 25-235 42-403 39-444 0-103
A dult healthy 99-257 318-1331 247-1372 5-204
(B) Surface IgM  and surface IgD on IgM- and IgD-containing cells
On small c !gM + c On large cIgM +i' On (large) cIgD+
Patient No. % slgM %  slgD %  slgM % slgD %  slgM %  slgD
1 69 43 67 1 20 93
2 65 65 88 39 70 76
3 74 68 26'’ 5 ' 22 59
4 42 34 49 15 7 77
5 100 66 81 71 0.2 91
6 67 62 76.5 26 37 85
7 39 16 62" 40" 10 98
8 59 42 86 33 46 90
9 51 20 80 12 0 69
10 58 41 46 6 7 94
13 82 76 92* 25c 16 94
14 16 2 No large cIgM + 0f 64<’
15 No small cIgM + No large clgM-t- 2 85
16 Not done N ot done Not done
17 53 40 45 60 2 89
18 71 57 93 56 80 100
"The italicized data indicate a deviation o f  the norm al values. 
*See Ref. 17.
‘Pre-B plus B cells.
''L arge lymphocytes and plasma cells.
cF ew er than 30 clg-positive cells per slide investigated.
did  no t evoke such an attack, ex cep t in pa tien t 5, 
w ho tu rned  out to  have been im m unized w ith H PH  
prev iously .
A nalysis of the num ber of T lym phocytes of the 
periphera l blood showed norm al resu lts  and the in 
vitro  p ro liferative response to m itogens, antigens, 
and  allogeneic cells did not show  abnorm alities 
(da ta  no t shown). Analysis of periphera l blood B 
lym phocytes for expression of su rface  IgM  and IgD 
show ed th a t patients 14, 15, and  16 did no t have
im m unoglobulin-bearing B lym phocy tes in the  pe­
ripheral blood. This finding is in agreem ent with the 
diagnosis o f  X -linked agam m aglobulinem ia (XLA) 
in p atien ts  14 and  15. H ow ever, th e  lack  of B cells 
in com m on variable hypogam m aglobulinem ia (pa­
tien t 16) is unusual. In  the  pa tien t w ith an  IgM 
deficiency, norm al o r even  increased  percentages of 
|j,+8+ cells w ere p resen t. In all o ther patien ts tested  
fo r the  p resence  o f (jl+ 8+ , and |x+8~ cells, no 
abnorm alities w ere  found  in the blood.
Journal o f  Clinical Immunology, Vol. 9, N o. 5, 1989
398 HIEMSTRA ET AL.
1000. 10000.100.
IgD in serum (Ill/ml)
Fig. 3. Correlation between the number o f IgD-containing plasma 
cells in bone m arrow  and the serum level o f IgD.
Bone m arrow  im m unofluorescence stud ies fo r 
p lasm a cells show ed an increase in IgD -containing 
cells in 14 o f 15 patients (Table IV A ). T h e  X L A  and 
com m on variable im m unodeficiency (CV ID ) p a ­
tien ts  show ed decreased  num bers o f  IgM -, IgG-, 
and  IgA -containing plasm a cells ex cep t fo r patient 
16, who show ed an increase in IgM -contain ing 
p lasm a cells, w hich is in agreem ent w ith  the p res­
ence of IgM in serum  (Table II). The p a tien t w ith an 
IgM  deficiency (patient 17) show ed slightly in­
c reased  num bers o f IgM plasm a cells, w hich  raises 
the question of the  reason  for the  deficiency in 
serum . Several patients show ed increased  levels o f 
p lasm a cells o f  one or m ore o f the th ree  m ajor Ig 
isotypes. O n analysis a  linear re la tionsh ip  (/- =  0.82) 
betw een  levels o f  serum  IgD and num bers o f IgD 
plasm a cells in bone m arrow  w as found (Fig. 3). 
A nalysis o f the kappa-to-lam bda ra tio  o f clgD  
plasm a cells show ed decreased values in 5 o f 13 
patien ts (data  not shown). T hese five patien ts  in­
cluded the patien ts  w ith an im m unodeficiency syn ­
drom e. N o a ttem pts w ere m ade to determ ine  the 
kappa-to-lam bda ratio in serum  IgD.
Com bined staining fo r m em brane and  cy top las­
m ic IgM  and IgD (see Table IVB) show ed  th a t the 
population  o f  small cIgM + cells, w hich  include 
pre-B  cells and B lym phocytes, may ex p ress  slgM  
and  slgD  sim ultaneously at a ra th e r high p e rcen t­
age. The X L A  patien t (No. 14) show s som e sIgM + 
B lym phocytes in the bone m arrow  w ith  alm ost no 
IgD  expression. In  patient 15 (XLA) no pre-B  cells
and B lym phocytes are detectable in the bone 
m arrow , w hich confirms the lack o f B cells in the 
peripheral blood. The large cIgM + cells still express 
surface IgM , but surface IgD expression is less than 
on the small clgM  cells. The phenom enon of disap­
pearance o f  surface IgD apparently  indicates m atu­
ration of B lym phocytes into p lasm a cells secreting 
only one Ig isotype, i.e ., IgM in this case. A parallel 
observation is m ade on large cIgD + cells which 
abundantly express slgD and, to a m uch lesser 
extent, slgM  (Table IVB), again indicating m atura­
tion of plasm a cells com m itted to p roduce IgD.
DISCUSSION
In recent years the structure  and m olecular biol­
ogy of hum an IgD have alm ost been  solved (5). In 
contrast, how ever, the biological function  o f this 
immunoglobulin isotype is far from  clear, and al­
m ost nothing is know n about the m eaning o f abnor­
mal serum  IgD concentrations in pa tien ts . In­
creased  serum  IgD co n cen tra tio n s  have been 
m entioned, e.g., in pregnancy (21) and in  a variety 
of diseases such as leprosy, tuberculosis (22), par­
asitic and fungi infection (23), H odgkin’s disease 
(24), and AIDS (25). M oreover, high serum  IgD has 
been reported in individual patients w ith various 
types of im m unodeficiency, am ong w hich ataxia 
telangiectasia and Rosen-type dysim m unoglobuli- 
naemia (26) and transient IgD increases have been 
found after allogeneic bone m arrow  transplantation  
(27).
In this study an extrem ely high serum  IgD level 
was found in the  eight patients suffering from  the 
so-called periodic fever hyper-IgD  syndrom e which 
was described by van der M eer et al. in 1984 (11). 
This syndrom e shows a  clinical sim ilarity to familial 
m editerranean fever (FM F), although in the latter 
C5a inhibitor deficiency is docum ented, w hereas 
serum IgD is not increased (11, 28). As argued 
earlier IgD elevation in periodic fever patien ts could 
be either a cause or an effect of an underlying 
abnorm ality, van der M eer e t al. (11) hypothesized 
that the syndrom e consists o f an exaggerated and 
uncontrolled type III hypersensitiv ity  reaction , pos­
sibly w ith involvem ent of IgD -containing immune 
com plexes. The occurrence of attacks w ithin 1 day 
after vaccinations w ith secondary antigens does 
support this assum ption. The striking success o f an 
allergen-free diet in patient 2 would also fit this 
concept. T he present study included the search for 
serum IgD com plexes; surprisingly these  w ere pre­
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sent in  every  serum  sample investigated , including 
those o f p a tien ts  not suffering from  periodic fever. 
A lthough the  com position o f th e  IgD  com plexes is 
unknow n, the ir presence in every  serum  sam ple 
indicates th a t they are no t pathognom ic for the 
syndrom e o f periodic fever. T hus the im m une com ­
plex n a tu re  o f this disease is as ye t not definitely 
proven. Selective dysregulation o f  IgD (and IgA) 
synthesis in periodic fever by an as y e t unexplained 
m echanism  should be envisaged as well and  this 
requires fu rth e r analysis.
W ith resp ec t to  the serum  IgM , IgG , and  IgA  
levels o f  the  patien ts , the m ost striking observation  
concerns the consisten t finding o f  increased  serum  
IgA in the  periodic fever patien ts (see also  Ref. 11). 
A  search  fo r IgA -containing com plexes w as no t 
included in  the study. In teresting ly  in  only one of 
the few  patien ts w ith periodic fev e r analyzed for 
IgA in saliva w as an increased level p resen t. C on­
cu rren t increases in serum  IgD and saliva IgD , 
although occurring  in  some p a tien ts , w ere also no t 
the ru le  (Table III). W e are inclined to  assum e th a t 
the serum  IgD o f the patients reflects predom inantly  
bone m arrow -derived IgD (see Fig. 3) and th a t only 
som e o f the  patien ts have increased  synthesis o f 
IgD a t th e  level o f the salivary gland.
A nalysis o f  in vivo IgG an tibody  p roduction  after 
challenge w ith te tanus toxoid did no t show abnor­
m alities. R ecently  L itw in and Z eh r (29) show ed an 
inverse correlation  betw een  high serum  IgD levels 
and low er levels o f  IgM -type an tibodies against 
phosphory l choline, te tanus to x o id , and pneum o­
coccal po lysaccharide type 3. O u r resu lts obtained 
with the prim ary antigen H P H  show ed  no correla­
tion betw een  IgM  anti-H PH  resp o n ses and the  level 
o f serum  IgD. F urtherm ore, only a  few patients 
show ed detectab le  IgD-class an tite tanus o r anti- 
H PH  antibodies. W e conclude th a t increases in 
serum  IgD do not imply the genera tion  o f  antibodies 
o f the  IgD  class in each individual. In  this re sp ec t it 
is in teresting  to  m ention the resu lts  o f T horbecke 
and co-w orkers (30, 31) who show ed  tha t in jection 
o f m yelom a IgD in mice resu lted  in  an enhanced  
overall antibody response upon  antigenic stim ula­
tion. This results suggests a  ro le fo r  IgD in the  
up-regulation o f  the hum oral im m une response. 
H ow ever, endogenous increased  IgD , as p resen t in 
our p a tien ts , does not lead to  an  enhanced  antibody 
response  upon  tetanus or H P H  im m unization.
L ym phocy te  studies did no t d isclose defects in 
T-cell function  in patients w ith  increased  serum  
IgD. H ow ever, the secretion o f various cy tokines
was no t investigated . A nalysis o f  the p recu rso r B 
lym phocytes fo r IgD p lasm a cells, i.e ., the  |j l+ 8 +  
and n T § + B cells also did no t show  abnorm alities. 
In  p articu lar, |aT8+ B cells are no t increased in 
e ither the  peripheral blood o r  the  bone m arrow . IgD 
plasm a cells in bone m arrow  w ere significantly 
increased  and a bone m arrow  origin o f  serum  IgD 
was strongly  suggested , as a linear re la tionsh ip  was 
detectab le  (Fig. 3). B one m arrow  origin of serum 
IgM , IgG, and IgA  has been  found earlier (32). The 
results on double staining fo r surface IgM  and IgD, 
on the  one hand , and cytoplasm ic IgM  and IgD , on 
the o ther, confirm  earlier observations th a t m atura­
tion o f  B lym phocytes into p lasm a cells is associ­
ated w ith a  p rep o n d eran ce  o f  surface Ig  o f the  sam e 
iso type as th a t o f the  cy toplasm  (33). This investi­
gation show s th a t this phenom enon  also  holds true 
for IgD.
T he resu lts  o f th is study  on  a varie ty  o f patients 
w ith strongly increased  serum  IgD do no t solve the 
questions concerning th e  heterogeneity  o f the asso­
ciated diseases and th e  underly ing imm unological 
abnorm ality . H ow ever, th is inven to ry  raises the 
question  w heth er there  is a certa in  parallel w ith the 
hyper-IgE  syndrom e w here  defective regulation o f 
IgE synthesis m ay be p a rt o f  the  d isease en tity  (34). 
We are  inclined to  suggest that regulation o f  IgD 
synthesis m ust be  investigated  in th is pa tien t group 
including T  delta  cells and th e ir  p ro d u c ts  (31). With 
respect to  the  syndrom e o f periodic fev er, no defi­
nite re la tionsh ip  betw een  th e  clinical signs and  the 
increased serum  IgD  is apparen t. E ven  the presence 
of IgD com plexes is no t con tribu to ry  since neither 
the n a tu re  and genesis no r the  im m unopathological 
consequences a re  clear. A  possib le  underestim ated  
property  o f  IgD consists o f  its capacity  to  bind 
bacteria  in a nonspecific w ay, i.e ., by virtue o f the 
Fc fragm ent (35). T he influence o f  th is phenom enon 
on the  c learance  o f  b ac te ria  in the in fected  host with 
increased  IgD syn thesis , is no t c lear and deserves 
investigation.
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